Proactive Wealth Strategies’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Buy
6,742
+54
+0.8% +$2.86K 0.06% 173
2026
Q1
$369K Buy
+6,688
New +$362K 0.07% 165

Other funds holding GSK

Proactive Wealth Strategies's GSK Position: Q2 2026 in Review

Proactive Wealth Strategies increased its GSK (GSK) stake by 0.81% in Q2 2026, buying an estimated $2.86K and bringing the position to 6,742 shares worth $353K. The position accounts for 0.06% of the portfolio, ranked #173.

Proactive Wealth Strategies first reported a position in GSK in Q1 2026 and has held it in 2 quarters since. The position peaked at $369K in Q1 2026. 683 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Proactive Wealth Strategies held 6,742 shares of GSK worth $353K as of Q2 2026.
  • Proactive Wealth Strategies bought 54 GSK shares in Q2 2026, an estimated $2.86K.
  • GSK made up 0.06% of Proactive Wealth Strategies's portfolio in Q2 2026, its #173 holding.
  • Proactive Wealth Strategies first reported a position in GSK in Q1 2026 and has held it in 2 quarters since.
  • Proactive Wealth Strategies's GSK position peaked at $369K in Q1 2026.
  • 683 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Proactive Wealth Strategies's 13F filing for Q2 2026, filed 10 Aug 2026.